These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32218098)

  • 21. Comparison between clinical features and prognosis of malignancy- and non-malignancy-associated pediatric hemophagocytic lymphohistiocytosis.
    Pan H; Huo Y; Sun L
    BMC Pediatr; 2019 Nov; 19(1):468. PubMed ID: 31783813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for early fatal outcomes among children with hemophagocytic lymphohistiocytosis (HLH): a single-institution case-series in Vietnam.
    Dao AT; Luong VT; Nguyen TT; Huynh QT; Phan TT; Lam MT; Ngoma AM; Koriyama C
    Pediatr Hematol Oncol; 2014 Apr; 31(3):271-81. PubMed ID: 24308730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis.
    Bami S; Vagrecha A; Soberman D; Badawi M; Cannone D; Lipton JM; Cron RQ; Levy CF
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28581. PubMed ID: 32725881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary hemophagocytic lymphohistiocytosis in pediatric patients: a single center experience and factors that influenced patient prognosis.
    Oguz MM; Sahin G; Altinel Acoglu E; Polat E; Yucel H; Oztek Celebi FZ; Unsal H; Akcaboy M; Sari E; Senel S
    Pediatr Hematol Oncol; 2019 Feb; 36(1):1-16. PubMed ID: 30821552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes and prognostic factors associated with 180-day mortality in Taiwanese pediatric patients with Hemophagocytic Lymphohistiocytosis.
    Yu TY; Lu MY; Lin KH; Chang HH; Chou SW; Lin DT; Jou ST; Yang YL
    J Formos Med Assoc; 2021 Apr; 120(4):1061-1068. PubMed ID: 33218852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fueling the FIRES: Hemophagocytic lymphohistiocytosis in febrile infection-related epilepsy syndrome.
    Farias-Moeller R; LaFrance-Corey R; Bartolini L; Wells EM; Baker M; Doslea A; Suslovic W; Greenberg J; Carpenter JL; Howe CL
    Epilepsia; 2018 Sep; 59(9):1753-1763. PubMed ID: 30132834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemophagocytic Lymphohistiocytosis in Children with Chronic Granulomatous Disease-Single-Center Experience from North India.
    Vignesh P; Loganathan SK; Sudhakar M; Chaudhary H; Rawat A; Sharma M; Shekar A; Vaiphei K; Kumar N; Singh Sachdeva MU; Jindal AK; Suri D; Gupta A; Ray P; Imai K; Ohara O; Nonoyama S; Lau YL; Singh S
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):771-782.e3. PubMed ID: 33259975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberculosis-associated hemophagocytic lymphohistiocytosis with initial presentation of fever of unknown origin in a general hospital: An analysis of 8 clinical cases.
    Zhang Y; Liang G; Qin H; Li Y; Zeng X
    Medicine (Baltimore); 2017 Apr; 96(16):e6575. PubMed ID: 28422850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human ehrlichiosis at a tertiary-care academic medical center: Clinical associations and outcomes of transplant patients and patients with hemophagocytic lymphohistiocytosis.
    Otrock ZK; Eby CS; Burnham CD
    Blood Cells Mol Dis; 2019 Jul; 77():17-22. PubMed ID: 30913447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and treatment of hemophagocytic lymphohistiocytosis in hospitalized children with Ehrlichia infection.
    Cabler SS; Hogan PG; Fritz SA; Bednarski JJ; Hunstad DA
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28436. PubMed ID: 32706439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of 9 cases of drug induced hypersensitivity syndrome related hemophagocytic lymphohistiocytosis].
    Zhao YZ; Ma HH; Wang D; Lian HY; Wang TY; Zhang R
    Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):60-65. PubMed ID: 38154979
    [No Abstract]   [Full Text] [Related]  

  • 32. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation.
    Castillo L; Carcillo J
    Pediatr Crit Care Med; 2009 May; 10(3):387-92. PubMed ID: 19325510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chediak-Higashi syndrome: Lessons from a single-centre case series.
    Carneiro IM; Rodrigues A; Pinho L; de Jesus Nunes-Santos C; de Barros Dorna M; Moschione Castro APB; Pastorino AC
    Allergol Immunopathol (Madr); 2019; 47(6):598-603. PubMed ID: 31477396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome analysis of pediatric hemophagocytic lymphohistiocytosis.
    Chen TY; Hsu MH; Kuo HC; Sheen JM; Cheng MC; Lin YJ
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 1):172-179. PubMed ID: 32307323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter study of patients with multisystem Langerhans cell histiocytosis who develop secondary hemophagocytic lymphohistiocytosis.
    Chellapandian D; Hines MR; Zhang R; Jeng M; van den Bos C; Santa-María López V; Lehmberg K; Sieni E; Wang Y; Nakano T; Williams JA; Fustino NJ; Astigarraga I; Dunkel IJ; Abla O; van Halteren AGS; Pei D; Cheng C; Weitzman S; Sung L; Nichols KE
    Cancer; 2019 Mar; 125(6):963-971. PubMed ID: 30521100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosis.
    Gurunathan A; Boucher AA; Mark M; Prus KM; O'Brien MM; Breese EH; Mizukawa BE; Absalon MJ; Nelson AS; Jordan MB; Grimley MS; Lorsbach RB; Rotz SJ; Mathanda R; Kumar AR
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27400. PubMed ID: 30272386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignancy-associated hemophagocytic lymphohistiocytosis in pediatric cases: a multicenter study from Turkey.
    Celkan T; Berrak S; Kazanci E; Ozyürek E; Unal S; Uçar C; Yilmaz S; Gürgey A
    Turk J Pediatr; 2009; 51(3):207-13. PubMed ID: 19817262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoalbuminaemia is an independent predictor for hemophagocytic lymphohistiocytosis in childhood Epstein-Barr virus-associated infectious mononucleosis.
    Huang SC; Chen JS; Cheng CN; Yang YJ
    Eur J Haematol; 2012 Nov; 89(5):417-22. PubMed ID: 22897479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Features and Prognostic Factors of Early Outcome in Pediatric Hemophagocytic Lymphohistiocytosis: A Retrospective Analysis of 227 Cases.
    Zhou YH; Han XR; Xia FQ; Poonit ND; Liu L
    J Pediatr Hematol Oncol; 2022 Jan; 44(1):e217-e222. PubMed ID: 34986134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and clinical presentation of primary hemophagocytic lymphohistiocytosis in Sweden.
    Meeths M; Horne A; Sabel M; Bryceson YT; Henter JI
    Pediatr Blood Cancer; 2015 Feb; 62(2):346-352. PubMed ID: 25382070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.